...40% of commercial revenue from the technology during the next five years and 20% thereafter. Incitive...
...failed to hit milestones, including delivery of small molecule inhibitors in an undisclosed time frame. Incitive...
...purified protease isolated from bromelain has completed preclinical testing to treat inflammatory bowel disease (IBD). Incitive Ltd....

...protease isolated from bromelain, which blocks the MAP kinase pathway to inhibit T cell activation. Incitive Ltd....

...protease isolated from bromelain, which blocks the MAP kinase pathway to inhibit T cell activation. Incitive Ltd....